| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/06/1995 | EP0669985A1 Conjugate vaccine against group b streptococcus |
| 09/06/1995 | EP0669927A1 Sequence-specific binding polymers for duplex nucleic acids |
| 09/06/1995 | EP0669925A1 Aids therapeutics based on hiv ma peptides |
| 09/06/1995 | EP0669833A1 USES OF TGF-$g(b) RECEPTOR FRAGMENT AS A THERAPEUTIC AGENT |
| 09/06/1995 | EP0669827A1 Compositions for the regulation of cytokine activity |
| 09/06/1995 | EP0617958A4 Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions. |
| 09/06/1995 | EP0574416B1 Poly-4-aminopyrrole-2-carboxyamide derivatives, processes for their preparation and pharmaceutical compositions which contain them |
| 09/06/1995 | EP0559815B1 Optically active thiazoloisoindolinone derivatives with an antiviral action |
| 09/06/1995 | CN1108030A New sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 09/06/1995 | CN1108029A Diamine salts of clavulanic acid |
| 09/06/1995 | CN1107850A Separation of cephalosporin isomers |
| 09/06/1995 | CN1107835A A process for preparing pharmaceutical composition showing properties in against human immunodeficiency virus |
| 09/05/1995 | US5447959 Vitamin A derivatives |
| 09/05/1995 | US5447950 Anthra[1,9-c,d]pyrazol-6-(2H)-ones useful for treating anaerobic bacterial infections |
| 09/05/1995 | US5447940 Reinforced collagen matrix, dispersed antibiotic, analgesic, antiinflammatory, antiseptic |
| 09/05/1995 | US5447926 Bactericides |
| 09/05/1995 | US5447925 Carbapenems with side-chain S; use to treat infections |
| 09/05/1995 | US5447915 Terminally blocked antiviral peptides |
| 09/05/1995 | US5447914 Bactericides, fungicides |
| 09/05/1995 | US5447913 Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
| 09/05/1995 | CA1336905C Pyrido [3,2,1,ij]-1,3,4-benzoxadiazine derivatives |
| 09/05/1995 | CA1336903C 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl adenosine derivatives |
| 09/05/1995 | CA1336890C Amphotericin b/cholesterol sulfate composition and method |
| 09/02/1995 | CA2138607A1 Formulations for orally administered pharmaceutical agents |
| 08/31/1995 | WO1995023166A1 Synthetic inverso or retro-inverso t-cell epitopes |
| 08/31/1995 | WO1995023160A1 Novel phosphoramidate and phophorothioamidate oligomeric compounds |
| 08/31/1995 | WO1995023157A1 4-n-substituted sialic acids and their sialosides |
| 08/31/1995 | WO1995023151A1 Pyrrolo(2,3-d)pyrimidine derivatives as antivirals |
| 08/31/1995 | WO1995023150A1 Carbapenem derivative |
| 08/31/1995 | WO1995023149A1 Phenylalkylamino derivatives of condensed carbapenemes |
| 08/31/1995 | WO1995023138A1 Pyrimidine acyclonucleoside derivatives |
| 08/31/1995 | WO1995023134A1 Therapeutic benzonitriles |
| 08/31/1995 | WO1995023133A1 Therapeutic benzonitriles |
| 08/31/1995 | WO1995023128A1 Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity |
| 08/31/1995 | WO1995022989A1 Vaccines containing paucilamellar lipid vesicles as immunological adjuvants |
| 08/31/1995 | WO1995022988A1 Vacuolating toxin-deficient h. pylori and related methods |
| 08/31/1995 | WO1995022987A1 Urease-based vaccine and treatment for helicobacter infection |
| 08/31/1995 | WO1995022985A1 Method for reproducing in vitro the proteolytic activity of the ns3 protease of hepatitis c virus (hcv) |
| 08/31/1995 | WO1995016036A3 IFN-ηRECEPTOR β-CHAIN AND DERIVATIVES THEREOF |
| 08/31/1995 | CA2184199A1 Pyrrolo(2,3-d)pyrimidine derivatives as antivirals |
| 08/31/1995 | CA2184155A1 Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity |
| 08/31/1995 | CA2184057A1 Urease-based vaccine and treatment for helicobacter infection |
| 08/31/1995 | CA2183977A1 Synthetic inverso or retro-inverso t-cell epitopes |
| 08/31/1995 | CA2183769A1 Vacuolating toxin-deficient h. pylori and related methods |
| 08/31/1995 | CA2181237A1 4-n-substituted sialic acids and their sialosides |
| 08/30/1995 | EP0669341A1 Therapeutic Nucleosides |
| 08/30/1995 | EP0668916A1 Haemophilus outer membrane protein |
| 08/30/1995 | EP0668871A1 Amino-acid sequence homologies between selectins and b. pertussis toxin-peptidesderived therfrom, antibodies thereto and pharmaceutical compositions |
| 08/30/1995 | EP0668870A1 Inhibitors of picornavirus proteases |
| 08/30/1995 | EP0668860A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses |
| 08/30/1995 | EP0668779A1 COMPOSITION PROTECTIVE AGAINST $i(P. MULTOCIDA) PASTEURELLOSIS INFECTION |
| 08/30/1995 | EP0668778A1 IMMUNIZATION AGAINST $i(NEISSERIA GONORRHOEAE) AND $i(NEISSERIA MENINGITIDIS) |
| 08/30/1995 | EP0668769A1 Synthetic compositions related to oak bark extrakt, and method of using same |
| 08/30/1995 | EP0668766A1 Small molecule inhibition of rna/ligand binding |
| 08/30/1995 | EP0630216A4 Adhesive bandages, wound dressings, sutures, drapes, orthodontic rubber bands, toothbrushes, and the like. |
| 08/30/1995 | EP0540686B1 2'-fluorofuranosyl derivatives and novel method of preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides |
| 08/30/1995 | CN1107341A Compound garlic oil capsule and its producing method |
| 08/29/1995 | US5446161 Amino acid derivatives |
| 08/29/1995 | US5446153 Intermediates for imidazo[4,5-c]pyridin-4-amines |
| 08/29/1995 | US5446139 Purine analog nucleoside and nucleotide compounds |
| 08/29/1995 | US5446052 Dialkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them |
| 08/29/1995 | US5446038 Microbiocides |
| 08/29/1995 | US5445820 Streptolysin O peptide antigens and methods for the determination of streptolysin antibodies |
| 08/29/1995 | US5445818 Synthetic pseudomonas aeruginosa pilin peptide vaccine and method of use |
| 08/29/1995 | CA2054870C Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives |
| 08/29/1995 | CA1336822C Intramuscular injection forms of gyrase inhibitors |
| 08/29/1995 | CA1336820C Fluorinated nucleosides and process for treating retrovirus infections therewith |
| 08/29/1995 | CA1336810C Synergistic interplay of lymphokines and double stranded rnas |
| 08/24/1995 | WO1995022604A1 Rna editing enzyme and methods of use thereof |
| 08/24/1995 | WO1995022563A1 Antigenic preparation for treatment or prevention of helicobacter infection |
| 08/24/1995 | WO1995022558A1 Method for the preparation of glycopeptidic antibiotic precursors by intramolecular cyclisation and formation of a biaryl ether bridge and novel compounds so obtained |
| 08/24/1995 | WO1995022553A1 Oligonucleotides with anti-respiratory syncytial virus activity |
| 08/24/1995 | WO1995022546A1 Intracellular signalling mediators |
| 08/24/1995 | WO1995022545A1 2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO[3,2-b:2',3'-e][1,4]DIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION |
| 08/24/1995 | WO1995022529A1 9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics |
| 08/24/1995 | WO1995022339A1 Cyclic heptapeptide anti-inflammatory agent |
| 08/24/1995 | WO1995022338A1 Broad spectrum antimicrobial compounds and methods of use |
| 08/24/1995 | WO1995022335A1 Acidified nitrite as an antimicrobial agent |
| 08/24/1995 | DE4421159C1 Use of ferric oxide for treating immune deficiency |
| 08/24/1995 | CA2183571A1 2-heteroaryl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection |
| 08/24/1995 | CA2183565A1 9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics |
| 08/24/1995 | CA2183562A1 Intracellular signalling mediators |
| 08/24/1995 | CA2183333A1 Method for the preparation of glycopeptidic antibiotic precursors by intramolecular cyclisation and formation of a biaryl ether bridge and novel compounds so obtained |
| 08/24/1995 | CA2183253A1 Rna editing enzyme and methods of use thereof |
| 08/24/1995 | CA2181827A1 Cyclic heptapeptide anti-inflammatory agent |
| 08/24/1995 | CA2181546A1 Oligonucleotides with anti-respiratory syncytial virus activity |
| 08/23/1995 | EP0668358A1 Antibiotic WAP-8294A, method for preparing the same and antibacterial composition |
| 08/23/1995 | EP0668077A1 Compositions containing G-CSF and TNF binding protein |
| 08/23/1995 | EP0667912A1 Defective adenovirus vectors and use thereof in gene therapy |
| 08/23/1995 | EP0667789A1 Restoration of immunocompetency to t helper cells in hiv infected patients |
| 08/23/1995 | EP0667787A1 Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines |
| 08/23/1995 | EP0667780A1 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents |
| 08/23/1995 | EP0500653A4 Inhibitors of purine nucleoside phosphorylase |
| 08/23/1995 | EP0500576B1 Outer membrane protein p1 and peptides of haemophilus influenzae type b |
| 08/23/1995 | CN1107152A Compound for inhibition of virus HIV of AIDS |
| 08/23/1995 | CN1107057A Children coryza medicine and preparing method |
| 08/23/1995 | CN1107040A Medicine bar for fumigation |
| 08/22/1995 | US5444174 Effective on grampositive bacteria |
| 08/22/1995 | US5444159 Purification of a pertussis outer membrane protein |
| 08/22/1995 | US5444063 95% free of corresponding beta-L enantiomer; oral or parenteral administeration |